BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 30539788)

  • 1. Macrophage Raptor Deficiency-Induced Lysosome Dysfunction Exacerbates Nonalcoholic Steatohepatitis.
    Liu W; Ye C; Cheng Q; Zhang X; Yao L; Li Q; Huang J; Liu Y; Zou Z; Wang H; Yan J; Zhu Y; Wang C; Ai D
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):211-231. PubMed ID: 30539788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine receptor CCR1 regulates macrophage activation through mTORC1 signaling in nonalcoholic steatohepatitis.
    Li H; Pan T; Gao L; Ding R; Yu Y; Ma M; Wang Y; Jin S; Chen Y; Ding C; Xu L
    Metabolism; 2024 Feb; 151():155758. PubMed ID: 38070823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.
    Wang Q; Zhou H; Bu Q; Wei S; Li L; Zhou J; Zhou S; Su W; Liu M; Liu Z; Wang M; Lu L
    J Hepatol; 2022 Aug; 77(2):312-325. PubMed ID: 35292349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
    J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
    Hirsova P; Ibrahim SH; Krishnan A; Verma VK; Bronk SF; Werneburg NW; Charlton MR; Shah VH; Malhi H; Gores GJ
    Gastroenterology; 2016 Apr; 150(4):956-67. PubMed ID: 26764184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
    Zhang X; Fan L; Wu J; Xu H; Leung WY; Fu K; Wu J; Liu K; Man K; Yang X; Han J; Ren J; Yu J
    J Hepatol; 2019 Jul; 71(1):163-174. PubMed ID: 30914267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA helicase DEAD-box protein 5 alleviates nonalcoholic steatohepatitis progression via tethering TSC complex and suppressing mTORC1 signaling.
    Zhang Y; Ye S; Lu W; Zhong J; Leng Y; Yang T; Luo J; Xu W; Zhang H; Kong L
    Hepatology; 2023 May; 77(5):1670-1687. PubMed ID: 35796622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis.
    Wang X; Hausding M; Weng SY; Kim YO; Steven S; Klein T; Daiber A; Schuppan D
    Antioxid Redox Signal; 2018 Jan; 28(2):87-109. PubMed ID: 28635324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival.
    Mridha AR; Haczeyni F; Yeh MM; Haigh WG; Ioannou GN; Barn V; Ajamieh H; Adams L; Hamdorf JM; Teoh NC; Farrell GC
    Clin Sci (Lond); 2017 Aug; 131(16):2145-2159. PubMed ID: 28687713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis.
    Lee C; Kim J; Han J; Oh D; Kim M; Jeong H; Kim TJ; Kim SW; Kim JN; Seo YS; Suzuki A; Kim JH; Jung Y
    Nat Commun; 2022 Jan; 13(1):578. PubMed ID: 35102146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
    Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
    Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH).
    Jindal A; Bruzzì S; Sutti S; Locatelli I; Bozzola C; Paternostro C; Parola M; Albano E
    Exp Mol Pathol; 2015 Aug; 99(1):155-62. PubMed ID: 26112094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β
    Drescher HK; Schippers A; Clahsen T; Sahin H; Noels H; Hornef M; Wagner N; Trautwein C; Streetz KL; Kroy DC
    J Hepatol; 2017 Jun; 66(6):1251-1264. PubMed ID: 28192190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth arrest and DNA damage-inducible 45α protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Tanaka N; Takahashi S; Hu X; Lu Y; Fujimori N; Golla S; Fang ZZ; Aoyama T; Krausz KW; Gonzalez FJ
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3170-3182. PubMed ID: 28844958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice.
    Kroy DC; Schumacher F; Ramadori P; Hatting M; Bergheim I; Gassler N; Boekschoten MV; Müller M; Streetz KL; Trautwein C
    J Hepatol; 2014 Oct; 61(4):883-90. PubMed ID: 24845607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-Inflammatory CXCR3 Impairs Mitochondrial Function in Experimental Non-Alcoholic Steatohepatitis.
    Du J; Zhang X; Han J; Man K; Zhang Y; Chu ES; Nan Y; Yu J
    Theranostics; 2017; 7(17):4192-4203. PubMed ID: 29158819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual role of protein tyrosine phosphatase 1B in the progression and reversion of non-alcoholic steatohepatitis.
    González-Rodríguez Á; Valdecantos MP; Rada P; Addante A; Barahona I; Rey E; Pardo V; Ruiz L; Laiglesia LM; Moreno-Aliaga MJ; García-Monzón C; Sánchez A; Valverde ÁM
    Mol Metab; 2018 Jan; 7():132-146. PubMed ID: 29126873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte-specific deletion of Brg1 alleviates methionine-and-choline-deficient diet (MCD) induced non-alcoholic steatohepatitis in mice.
    Kong M; Chen X; Xu H; Wenping ; Fang M; Xu Y
    Biochem Biophys Res Commun; 2018 Sep; 503(1):344-351. PubMed ID: 29890136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy.
    Zhang X; Han J; Man K; Li X; Du J; Chu ES; Go MY; Sung JJ; Yu J
    J Hepatol; 2016 Jan; 64(1):160-70. PubMed ID: 26394162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.